We back our commitment to helping provide 7 billion people access to high quality medicine with an industry-leading and continually expanding portfolio. Not only are we one of the world’s largest generics and speciality pharmaceutical companies, we’re also one of the largest manufacturers of active pharmaceutical ingredients (API).

Last Updated  27/02/2015